Phospholipid vesicles have been extensively investigated because of their usefulness as models for biological membranes and their potential application as carriers for drug delivery. However, preparations of small sonicated vesicles tend to aggregate and fuse (on storage at room temperature and at 4°C), resulting in significant changes in turbidity, rate of uptake by macrophage, and proton NMR linewidths. By modification of the surface of phospholipid vesicles with charged groups such as 11-aminogalactose that extend significantly from the vesicle surface, it is possible to obtain preparations that are stable for >7 days.Phospholipid vesicles have been extensively investigated because of their usefulness as models for biological membranes and their potential application as carriers for drug delivery (1-4). We have recently found that modification of the surface of distearoyl phosphatidylcholine vesicles by specific synthetic glycolipid determinants can affect the rate of uptake of these vesicles by mouse peritoneal macrophage in vitro and the differential tissue distribution of these vesicles in vivo in mice (5-9). However, small sonicated vesicles are thermodynamically unstable, and the properties of these vesicles can change significantly in the temperature range at which phase transitions occur (10-12). In particular, small sonicated vesicles tend to aggregate and fuse below the phase transition temperature, resulting in an increase in vesicle size as a function oftime (13-16). As these changes will ultimately affect the practical usefulness of phospholipid vesicles for drug delivery, we report in this paper studies of the effect of surface modification on the aggregation and fusion of phospholipid vesicles and on the rate of uptake of these vesicles by mouse peritoneal macrophage.
MATERIALS AND METHODSMaterials. L-a-Distearoyl phosphatidylcholine (Ste2PtdCho) from Calbiochem and cholesterol (Chol) from Sigma were used without further purification. Mannosyl, aminomannosyl, and aminogalactosylderivatives ofChol [6-(5-cholesten-3/3-yloxy)hexyl 1-thio-a-D-mannopyranoside (ManChol), 6-(5-cholesten-316 yloxy)hexyl 6-amino-6-deoxy-1-thio-a-D-mannopyranoside (NH2ManChol), and 6-(5-cholesten-3f3-yloxy)hexyl 6-amino-6-deoxy-l-thio-,f-D-galactopyranoside (NH2GalChol), respectively] were synthesized at Merck. [oleate-1-'4C]Cholesteryl oleate (specific activity, 51 Ci/mol; 1 Ci = 3.7 x 10'°becque-rels) was purchased from New England Nuclear.Newborn calf serum, medium-199, and penicillin/streptomycin were purchased from Microbiological Associates (Los Angeles, CA) and plastic Petri dishes (35 x 10 mm) were obtained from Falcon. D20 (99.8% D) was purchased from Aldrich.Preparation of Liposomes. Small unilamellar vesicles were prepared according to the method ofMauk and colleagues (5-9). Briefly, a lipid mixture was prepared by mixing Ste2PtdCho, Chol, NH2ManChol (or NH2GalChol), and A23, 2:0.5:0.5:0.004 (mol/mol) or as otherwise specified. The mixture was dried in vacuum overnight and then probe sonicated in phosph...